Research article · 23 Aug 2023
Conference abstractPublished 2 Oct 2017
VasQ™ device improves functionality of arteriovenous fistulas: Randomized-controlled study
Guys hospital; Great Maze Pond, London, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Despite its clear benefits, early failure occurs in over 40% of surgically created fistulas. VasQ, a novel external support device designed to optimize anastomosis geometry, regulate flow patterns, and supports the venous wall, thereby facilitating fistula maturation and patency. The following are results of a multinational prospective, randomized-controlled study which includes 40 Device and 20 control patients, assessing VasQâÂ?¢ safety, usability and effectiveness in patients requiring new BrachioCephalic Fistula (BCF). Device implantation easily integrated with the routine fistula procedure. All patients were free from any device related complications. Higher functional maturation rates were observed for patients implanted with VasQ compared to the control group at 3 months (77% vs. 45% p=0.02) and 6 months (88% vs. 50% p=0.02). After 6 months, primary patency rate was 79% device vs. 70% control, and secondary patency was 87% device vs. 70% control. Venous outflow by Doppler at 1 month was 1214ml/min device vs. 1208 ml/min control, 3 months 1426 ml/min device vs. 1174ml/min control, and 6 months 1269ml/min device vs. 1193 ml/min control. Vein diameter at 1 month was 6.7mm for both device and control, 3 months 8.5mm device vs. 6.9mm control (p=0.0044), and 6 months 10.1mm device vs. 8.3mm control (p=0.0115). VasQâÂ?¢ significantly increased fistula usability for hemodialysis, with superior maturation and patency rates. The improved functionality of the fistula using VasQâÂ?¢ may be related to decreased stenosis and occlusion events.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 16 Feb 2026
Risk Prediction Models for Autogenous Arteriovenous Fistula Maturation Failure in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis
Research article · 27 Oct 2023
Unlocking Hemodialysis Success: Navigating Arteriovenous Fistula Maturation Factors for Optimal Access
Perspective · 22 Jun 2023
An Overview of Arteriovenous Fistula and Graft Failure: Causes, Interventions, and Risks
Conference abstract · 2022
Microsurgical approach for arteriovenous fistula creation in pediatric patients undergoing hemodialysis
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Research article · 15 Apr 2026
Anemia Management in Hemodialysis Patients in a Low-resource Setting: Blood Transfusion and Unmet Blood Needs in Burkina Faso
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “N. Karydis”

